Biodesix

  • Home
  • Contact us
  • Investors
  • Terms & Conditions
  • Careers
  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
  • Technology
    • Overview
    • ProTS in Depth
    • Technical Papers
  • Products
    • Overview
    • VeriStrat
    • CLIA Laboratory
  • Companion Dx
    • Overview
    • Bio/Pharma Collaboration
    • Case Study
  • Collaboration
    • Overview
    • Clinical Investigators
    • Academic Collaboration
    • Clinical Papers
  • News
    • Press Releases
    • In the News
    • Events
    • Press Releases
    • In the News
    • Events

    Archives

    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • Data

    • Clinical Publications
    • Technical Publications
  • February 22nd, 2012
    Biodesix Relocates to Boulder, CO
    January 30th, 2012
    Biodesix Receives New EU and US Patents for Blood-based Oncology Tests
    December 7th, 2011
    VeriStrat® Test Predicts Outcomes in Advanced Breast Cancer Patients
    December 5th, 2011
    Biodesix Receives 2011 North American Cancer Diagnostics Product Differentiation Excellence Award
    November 22nd, 2011
    Biodesix Announces New VeriStrat® Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
    November 2nd, 2011
    Lung Cancer Study Evaluating Changes in VeriStrat Status over the Course of Treatment with Gefitinib Published in Journal of Thoracic Oncology
    October 24th, 2011
    Biodesix to Present at BioConference Live – Innovative Online Conference
    October 18th, 2011
    VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients
    October 13th, 2011
    Biodesix to Work with Concentra and Hooper Holmes to Expand Access to VeriStrat®
    September 27th, 2011
    Biodesix Selected to Present at Multi-State Investor and Partnering Conference
    « Older Entries

    Copyright 2011 Biodesix, All rights reserved